Newcastle University spinout Orla Protein Technologies's collaboration with Japan Radio Co raises more investment to carry on developing its infectious sample detector.
OJ Bio, a UK-based company created through a joint venture that included Newcastle University spinout Orla Protein Technologies, has raised an undisclosed amount from Japan-based Japan Radio Co.
OJ Bio aims to make the detection of infectious diseases in samples easier and quicker. It has completed the creation of a development prototype for its biochip technology that displays the results on a computer or app.
The funding from Japan Radio Co will allow OJ Bio to expand its production and business development.
Dale Athey, chief executive of OJ Bio, said: “We are at the leading edge of wireless point of care diagnostics, but the highly specialist and advanced scientific areas we are working in means that product and technology development lead times are lengthy.
“This new support from our Japanese partners means we can continue to build momentum towards the successful commercialisation of the technology. In particular, it will enable us to respond positively to the considerable interest that has been expressed in our device from medical, dental, veterinary, cosmetics and other sectors.”
Tatsuro Masamura, director and executive officer of JRC, said: “This has been a highly successful collaboration and the medical device products now being jointly developed have considerable global market potential.”
